home / stock / lptx / lptx news


LPTX News and Press, Leap Therapeutics Inc. From 09/16/21

Stock Information

Company Name: Leap Therapeutics Inc.
Stock Symbol: LPTX
Market: NASDAQ
Website: leaptx.com

Menu

LPTX LPTX Quote LPTX Short LPTX News LPTX Articles LPTX Message Board
Get LPTX Alerts

News, Short Squeeze, Breakout and More Instantly...

LPTX - LKCO, MSFT: The Big Autonomous Driving News Revving Up Luokung Technology Stock Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Luokung Technology (NASDAQ: LKCO ) stock is revving up on Thursday after revealing a deal with Microsoft (NASDAQ: MSFT ) that has investors excited. LKCO is a Chinese spatial-temporal intelligent big data servic...

LPTX - LPTX Stock: What Leap Therapeutics Investors Are Clicking Their Heels About Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Leap Therapeutics (NASDAQ: LPTX ) stock is on the move today following an update from the biotechnology company. Its focus is on developing targeted and immuno-oncology therapeutics and we’ve seen shares trendi...

LPTX - TUEM, OPAD and IRNT among pre market gainers

IronNet (NYSE:IRNT) +53%. Offerpad Solutions (NYSE:OPAD) +35%. Leap Therapeutics (NASDAQ:LPTX) +33% on positive DKN-01 + tislelizumab data in gastroesophageal cancer Phio Pharmaceuticals (NASDAQ:PHIO) +20% after mPH-3861 showed durable and systemic anti-tumor immune respon...

LPTX - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning. investor! We’re over halfway through the week now but we’re not slacking with our biggest pre-market stock movers for Thursday. Source: oneinchpunch/Shutterstock.com We’re seeing q...

LPTX - Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO Congress

Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO Congress - DKN-01 plus tislelizumab and chemotherapy demonstrated compelling activity in first-line patients with gastric or gastroesophageal junction cancer -...

LPTX - 3 Top Penny Stocks to Watch That Are Trending Right Now

Are These Trending Penny Stocks Worth Buying in 2021? Finding trending penny stocks to buy in 2021 can be challenging with so many names out there. But, there are a few tips you can use to make your penny stocks watchlist as competitive as can be. The first and most important step i...

LPTX - ATER, AXTI and OIIM among mid-day movers

Gainers: Itamar (NASDAQ:ITMR) +46%. Aterian (NASDAQ:ATER) +40%. aTyr Pharma (NASDAQ:LIFE) +37%. iRhythm Technology (NASDAQ:IRTC) +34%. BELLUS (NASDAQ:BLU) +26%. Leap Therapeutics  (NASDAQ:LPTX) +30%. REGENXBIO (NASDAQ:RGNX) +25%. Datasea (NASDAQ:DTSS) +20%. Uranium Royalty (NASDAQ:UROY) ...

LPTX - OCGN Stock: What Ocugen Investors Are Saying as Shares Surge Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ocugen (NASDAQ: OCGN ) stock is on the move today as traders push the company higher in a new rally for the shares. Source: Shutterstock OCGN stock is a favorite among meme stock traders on Reddit and other fo...

LPTX - IRTC Stock: 7 Things to Know About Digital Healthcare Play iRhythm Technologies as Shares Soar

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Irhythm Technologies (NASDAQ: IRTC ) stock is taking off on Monday after announcing Quentin Blackford as its next CEO. Source: ESB Professional/Shutterstock.com Blackford will be joining iRhythm Technologies s...

LPTX - LPTX Stock: Why Leap Therapeutics Just Soared 30% to Start the Day

InvestorPlace - Stock Market News, Stock Advice & Trading Tips For anyone suffering from gastric or gastroesophageal junction cancer, a recent breakthrough from Leap Therapeutics (NASDAQ: LPTX ) has yielded seemingly promising results for a method of treatment. This morning, the ...

Previous 10 Next 10